Navigating Your Journey: What is the Usual Dose of Ozempic

Last reviewed: June 25, 2026

Last updated: June 25, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist that works by slowing stomach emptying and signaling fullness to your brain, helping reduce appetite and calorie intake. Most patients begin at the lowest dose and gradually increase over 16 weeks to reach their maintenance level. Understanding how dosing works—and which dose might work best for your body—can help you make informed decisions about your weight loss journey.

Understanding Standard Semaglutide Dosing Schedules

The typical semaglutide injection protocol spans four months, starting with 0.25 mg weekly for the first four weeks. Weeks five through eight increase to 0.5 mg weekly, a dose that many patients find effective for initial weight loss. Weeks nine through twelve move to 0.75 mg weekly, and weeks thirteen through sixteen reach the standard maintenance dose of 1.0 mg weekly. This gradual approach allows your body to adapt to the medication's effects while reducing nausea and gastrointestinal discomfort that can occur with rapid dose increases.

Some patients require doses higher than 1.0 mg weekly based on individual response and clinical goals. Doctors may recommend increases to 1.5 mg or 2.0 mg weekly for patients who plateau or need additional metabolic support. The key principle is that your dose may need adjustment over time—but at PlexusDx, your monthly price remains flat regardless of which dose strength you're using. This pricing model removes the financial barrier that often prevents patients from reaching their optimal therapeutic dose.

How Your Body Responds to Semaglutide at Each Stage

During the initial 0.25 mg phase, most patients notice mild appetite suppression and may experience some nausea or stomach changes as their body adjusts to GLP-1 activation. By week five at 0.5 mg, satiety signals strengthen considerably—many patients report feeling fuller on smaller portions and losing interest in previously craved foods. The appetite reduction becomes more pronounced at 0.75 mg and 1.0 mg, with typical weight loss averaging 1–2 pounds per week during the first three months of consistent therapy.

The PlexusDx Precision Peptide Genetic Test analyzes FTO — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Compounded vs. Brand-Name Semaglutide: What You Should Know

Brand-name Ozempic and compounded semaglutide contain the same active pharmaceutical ingredient and work identically in your body. The difference lies in cost, access, and production oversight. Brand medications are mass-manufactured by large pharmaceutical companies and often cost $900–$1,500 per month even with insurance. Compounded semaglutide is prepared by licensed 503A compounding pharmacies under strict quality standards and typically costs a fraction of brand pricing while maintaining the same clinical effectiveness.

PlexusDx sources semaglutide from licensed 503A compounding pharmacies in all 50 states, offering injectable semaglutide at $189/mo month-to-month, or from $149/mo on the 6-month plan with no insurance requirement and no membership fees. Every batch meets pharmaceutical-grade standards for purity and sterility. Your dose may increase during your treatment journey—but your monthly price remains fixed, ensuring you can afford to reach your optimal therapeutic dose without financial surprises.

Personalizing Your Semaglutide Protocol With Genetic Insights

The PlexusDx Precision Peptide Genetic Test analyzes FTO (rs9939609) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Understanding your genetic baseline helps PlexusDx clinicians recommend your ideal starting dose, expected escalation speed, and most effective medication choice. Patients with strong GLP-1 receptor sensitivity may achieve results at lower doses, reducing side effects and maximizing affordability. Those with genetic variants affecting satiety signaling may need higher doses or combination therapy. This precision approach—available for $298—transforms weight loss from guesswork into personalized science.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the standard starting dose of semaglutide for weight loss?

The typical starting dose is 0.25 mg injected once weekly for the first four weeks. This low-dose introduction minimizes nausea and allows your body to adapt. PlexusDx delivers compounded semaglutide at this dose level at $189/mo month-to-month, or from $149/mo on the 6-month plan, with your price locked in even if your dose increases over time.

How long does it take to reach the maintenance dose of semaglutide?

The standard 16-week escalation protocol typically has you reach 1.0 mg weekly by week 16. However, some patients reach therapeutic benefit at 0.75 mg and remain there, while others eventually escalate to 1.5–2.0 mg based on clinical response. Your dosing timeline depends on your tolerance, weight loss progress, and individual metabolism.

Why does PlexusDx keep pricing flat across all dose levels?

PlexusDx operates on a principle that cost should never prevent you from reaching your optimal dose. Your monthly price remains the same whether you're taking 0.25 mg or 2.0 mg weekly, removing financial barriers to dose optimization and ensuring you can access the therapy strength your body actually needs.

What side effects should I expect when starting semaglutide?

Common initial side effects include mild to moderate nausea, constipation, and decreased appetite—ironically, appetite suppression is the desired therapeutic effect. Nausea typically peaks in the first week and diminishes by week three as your body adjusts. Staying hydrated, eating smaller meals, and taking doses consistently help minimize discomfort. Most side effects resolve by week four, and serious adverse events are rare.

How can the Precision Peptide Genetic Test improve my semaglutide outcomes?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (FTO) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic Starting Dose
• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.